Could a weekly shot reduce heart risks for people with HIV?
NCT ID NCT04019197
Summary
This study is testing whether a weekly injection of semaglutide, a medication used for weight loss and diabetes, can reduce harmful fat buildup in people living with HIV. The trial involves 108 adults with HIV who have a specific fat redistribution condition. Researchers will measure changes in body fat, inflammation, and markers of heart disease risk over 32 weeks of treatment, followed by 24 weeks of observation.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Case Western Reserve University
Cleveland, Ohio, 44106, United States
-
Medical University of South Carolina
Charleston, South Carolina, 29425, United States
Conditions
Explore the condition pages connected to this study.